Article
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.
Nature - 5 May 2016
Gautam Rajeev, Nishimura Yoshiaki, Pegu Amarendra, Nason Martha C, Klein Florian, Gazumyan Anna, Golijanin Jovana, Buckler-White Alicia, Sadjadpour Reza, Wang Keyun, Mankoff Zachary, Schmidt Stephen D, Lifson Jeffrey D, Mascola John R, Nussenzweig Michel C, Martin Malcolm A
Abstract excerpt
Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in generating an effective HIV-1 vaccine. Although passive transfer of anti-HIV-1 broadly neutralizing antibodies can protect mice or macaques against a single high-dose challenge with HIV or simian/human (SIV/HIV) chimaeric viruses (SHIVs) respectively, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
